Literature DB >> 25990863

Transcription factor networks in B-cell differentiation link development to acute lymphoid leukemia.

Rajesh Somasundaram1, Mahadesh A J Prasad1, Jonas Ungerbäck1, Mikael Sigvardsson1.   

Abstract

B-lymphocyte development in the bone marrow is controlled by the coordinated action of transcription factors creating regulatory networks ensuring activation of the B-lymphoid program and silencing of alternative cell fates. This process is tightly connected to malignant transformation because B-lineage acute lymphoblastic leukemia cells display a pronounced block in differentiation resulting in the expansion of immature progenitor cells. Over the last few years, high-resolution analysis of genetic changes in leukemia has revealed that several key regulators of normal B-cell development, including IKZF1, TCF3, EBF1, and PAX5, are genetically altered in a large portion of the human B-lineage acute leukemias. This opens the possibility of directly linking the disrupted development as well as aberrant gene expression patterns in leukemic cells to molecular functions of defined transcription factors in normal cell differentiation. This review article focuses on the roles of transcription factors in early B-cell development and their involvement in the formation of human leukemia.
© 2015 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25990863      PMCID: PMC4505011          DOI: 10.1182/blood-2014-12-575688

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  128 in total

1.  Early B cell factor 1 regulates B cell gene networks by activation, repression, and transcription- independent poising of chromatin.

Authors:  Thomas Treiber; Elizabeth M Mandel; Sebastian Pott; Ildiko Györy; Sonja Firner; Edison T Liu; Rudolf Grosschedl
Journal:  Immunity       Date:  2010-05-06       Impact factor: 31.745

2.  Deregulation of PAX-5 by translocation of the Emu enhancer of the IgH locus adjacent to two alternative PAX-5 promoters in a diffuse large-cell lymphoma.

Authors:  M Busslinger; N Klix; P Pfeffer; P G Graninger; Z Kozmik
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

3.  Essential functions of Pax5 (BSAP) in pro-B cell development: difference between fetal and adult B lymphopoiesis and reduced V-to-DJ recombination at the IgH locus.

Authors:  S L Nutt; P Urbánek; A Rolink; M Busslinger
Journal:  Genes Dev       Date:  1997-02-15       Impact factor: 11.361

4.  Multilineage gene expression precedes commitment in the hemopoietic system.

Authors:  M Hu; D Krause; M Greaves; S Sharkis; M Dexter; C Heyworth; T Enver
Journal:  Genes Dev       Date:  1997-03-15       Impact factor: 11.361

5.  IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL.

Authors:  R P Kuiper; E Waanders; V H J van der Velden; S V van Reijmersdal; R Venkatachalam; B Scheijen; E Sonneveld; J J M van Dongen; A J P Veerman; F N van Leeuwen; A Geurts van Kessel; P M Hoogerbrugge
Journal:  Leukemia       Date:  2010-05-06       Impact factor: 11.528

6.  Revised map of the human progenitor hierarchy shows the origin of macrophages and dendritic cells in early lymphoid development.

Authors:  Sergei Doulatov; Faiyaz Notta; Kolja Eppert; Linh T Nguyen; Pamela S Ohashi; John E Dick
Journal:  Nat Immunol       Date:  2010-06-13       Impact factor: 25.606

7.  Chromosomal translocations involving the E2A gene in acute lymphoblastic leukemia: clinical features and molecular pathogenesis.

Authors:  S P Hunger
Journal:  Blood       Date:  1996-02-15       Impact factor: 22.113

8.  Cooperation between deficiencies of IRF-4 and IRF-8 promotes both myeloid and lymphoid tumorigenesis.

Authors:  Seung-Hee Jo; Jonathan H Schatz; Jaime Acquaviva; Harinder Singh; Ruibao Ren
Journal:  Blood       Date:  2010-06-28       Impact factor: 22.113

9.  The t(9;14)(p13;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene.

Authors:  S Iida; P H Rao; P Nallasivam; H Hibshoosh; M Butler; D C Louie; V Dyomin; H Ohno; R S Chaganti; R Dalla-Favera
Journal:  Blood       Date:  1996-12-01       Impact factor: 22.113

10.  B-lymphocyte development is regulated by the combined dosage of three basic helix-loop-helix genes, E2A, E2-2, and HEB.

Authors:  Y Zhuang; P Cheng; H Weintraub
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

View more
  53 in total

1.  Aryl hydrocarbon receptor activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin impairs human B lymphopoiesis.

Authors:  Jinpeng Li; Ashwini S Phadnis-Moghe; Robert B Crawford; Norbert E Kaminski
Journal:  Toxicology       Date:  2016-12-31       Impact factor: 4.221

2.  Progression of progenitor B-cell leukemia is associated with alterations of the bone marrow micro-environment.

Authors:  Josefine Åhsberg; Pingnan Xiao; Kazuki Okuyama; Rajesh Somasundaram; Tobias Strid; Hong Qian; Mikael Sigvardsson
Journal:  Haematologica       Date:  2019-07-11       Impact factor: 9.941

3.  Cellular plasticity in B-cell leukemia.

Authors:  Rajesh Somasundaram; Tobias Strid; Mikael Sigvardsson
Journal:  Cell Cycle       Date:  2017-01-24       Impact factor: 4.534

4.  Dynamic pre-BCR homodimers fine-tune autonomous survival signals in B cell precursor acute lymphoblastic leukemia.

Authors:  M Frank Erasmus; Ksenia Matlawska-Wasowska; Ichiko Kinjyo; Avanika Mahajan; Stuart S Winter; Li Xu; Michael Horowitz; Diane S Lidke; Bridget S Wilson
Journal:  Sci Signal       Date:  2016-11-29       Impact factor: 8.192

5.  Nonpermissive bone marrow environment impairs early B-cell development in common variable immunodeficiency.

Authors:  Arianna Troilo; Claudia Wehr; Iga Janowska; Nils Venhoff; Jens Thiel; Justyna Rawluk; Natalie Frede; Julian Staniek; Raquel Lorenzetti; Marei-Theresa Schleyer; Georg W Herget; Lukas Konstantinidis; Miriam Erlacher; Michele Proietti; Nadezhda Camacho-Ordonez; Reinhard Edmund Voll; Bodo Grimbacher; Klaus Warnatz; Ulrich Salzer; Marta Rizzi
Journal:  Blood       Date:  2020-04-23       Impact factor: 22.113

6.  IMiD compounds affect CD34+ cell fate and maturation via CRBN-induced IKZF1 degradation.

Authors:  Shirong Li; Jing Fu; Hui Wang; Huihui Ma; Xiaoming Xu; Yong-Guang Yang; Shixian Deng; Markus Y Mapara; Suzanne Lentzsch
Journal:  Blood Adv       Date:  2018-03-13

7.  Predicting leukemia relapse.

Authors:  José Ignacio Martín-Subero
Journal:  Nat Med       Date:  2018-04-10       Impact factor: 53.440

8.  5-Azacytidine prevents relapse and produces long-term complete remissions in leukemia xenografts treated with Moxetumomab pasudotox.

Authors:  Fabian Müller; Tyler Cunningham; Stephanie Stookey; Chin-Hsien Tai; Sandra Burkett; Parthav Jailwala; Maryalice Stetler Stevenson; Margaret C Cam; Alan S Wayne; Ira Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-05       Impact factor: 11.205

9.  A High-Resolution Genome-Wide CRISPR/Cas9 Viability Screen Reveals Structural Features and Contextual Diversity of the Human Cell-Essential Proteome.

Authors:  Thierry Bertomeu; Jasmin Coulombe-Huntington; Andrew Chatr-Aryamontri; Karine G Bourdages; Etienne Coyaud; Brian Raught; Yu Xia; Mike Tyers
Journal:  Mol Cell Biol       Date:  2017-12-13       Impact factor: 4.272

10.  The Ring Finger Protein RNF6 Induces Leukemia Cell Proliferation as a Direct Target of Pre-B-cell Leukemia Homeobox 1.

Authors:  Xin Xu; Kunkun Han; Xiaowen Tang; Yuanying Zeng; Xu Lin; Yun Zhao; Zubin Zhang; Biyin Cao; Depei Wu; Xinliang Mao
Journal:  J Biol Chem       Date:  2016-03-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.